Insights from 2023 ASCO® Annual Meeting


 

Concurrent Chemo-Hormonal Therapy of Enzalutamide and Cabazitaxel in Patients With mCRPC: Final Analysis of ORR, rPFS, and OS

341 views
September 12, 2023
Comments 0
Login to view comments. Click here to Login